Glucotrack, Inc. current report, 13 April 2017

Business Context and Reporting Period

This Form 8-K is a current report filed by Integrity Applications, Inc. (not Glucotrack, Inc., as noted in the metadata) on April 13, 2017, covering events that occurred on April 7, 2017. The filing details significant changes in corporate governance, executive compensation, and equity incentive plans.

Key Financial Metrics and Compensation Arrangements

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or debt levels. Instead, it discloses specific financial commitments related to executive compensation and equity grants:

  • Avner Gal (Former Director/Consultant): Agreement includes payment of salary and benefits for the notice period, an adjustment period equivalent to 24 salaries, acceleration of 88,259 unvested options (exercise price $6.25), extension of option terms to five years, and new grants for 300,000 shares ($4.50 exercise price) and 50,000 shares ($7.75 exercise price).
  • John Graham (CEO): Base salary set at $500,000 per year plus a one-time commencement payment of $375,000. Equity vesting modified: 307,754 shares vest immediately, 923,262 shares vest in six months, and the remainder vests in two years.
  • David Malka (VP of Operations): Base monthly salary of NIS 20,000 (approx. $5,480), potentially increasing to NIS 35,000 (approx. $9,590) upon meeting milestones. Eligible for an annual performance bonus of 420-864% of base salary and a retention bonus of 60% of aggregate base salary earned in the first year.
  • Equity Plan: The 2010 Incentive Compensation Plan was amended to increase reserved shares from 1,000,000 to 5,625,000.

Material Changes Versus Prior Period

The filing reports the following material changes effective April 7, 2017:

  • Departure of Director: Avner Gal resigned as a director but was appointed Chairman Emeritus and a member of the Scientific Advisory Board.
  • Executive Compensation: Significant amendments to employment agreements for John Graham and David Malka, including salary adjustments, one-time payments, and accelerated equity vesting.
  • Equity Pool Expansion: A 462.5% increase in the number of shares reserved for issuance under the company's incentive compensation plan.

Guidance, Outlook, and Risks

The filing does not contain forward-looking financial guidance, revenue outlook, or management commentary on business strategy. The primary risks and contingencies disclosed relate to:

  • Severance Obligations: The Malka Employment Agreement includes a severance provision requiring payment of base salary and benefits if terminated without cause prior to the expiration of the 90-day notice period.
  • Performance Milestones: David Malka's salary increase and bonus eligibility are contingent on meeting performance criteria to be established by the Board.
  • Non-Compete Clauses: Avner Gal's adjustment period benefits are conditional on him not working for a direct competitor.

Important Facts for Investor Verification

  • Verify the total cash outflow impact of the one-time payments to John Graham ($375,000) and the severance/notice period payments to Avner Gal.
  • Confirm the dilution impact of the new equity grants to Avner Gal (350,000 new shares) and the acceleration of existing options for Gal, Graham, and Malka.
  • Review the specific performance milestones required for David Malka's salary increase and bonus, as these are not detailed in the summary.
  • Check the company's current cash position to ensure it can fund the immediate cash payments and future salary obligations disclosed.